(Q44210748)

English

Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy

scientific article published in November 2002

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Effects of long-term beta-blocker (metoprolol or carvedilol) therapy on QT variability in subjects with chronic heart failure secondary to ischemic cardiomyopathy (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

author name string

Gianfranco Piccirillo

1

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Raffaele Quaglione

2

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Marialuce Nocco

3

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Camilla Naso

4

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Antonio Moisè

5

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Marco Lionetti

6

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Silvia Di Carlo

7

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Vincenzo Marigliano

8

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

language of work or name

0 references

publication date

1 November 2002

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

90

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

1113-1117

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

QT dispersion and sudden unexpected death in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Beat-to-beat QT interval variability: novel evidence for repolarization lability in ischemic and nonischemic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Beat-to-beat repolarization lability identifies patients at risk for sudden cardiac death

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Temporal repolarization lability in hypertrophic cardiomyopathy caused by beta-myosin heavy-chain gene mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Influence of age, the autonomic nervous system and anxiety on QT-interval variability

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Carvedilol in elderly patients with chronic heart failure, a 12 weeks randomized, placebo controlled open trial.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF)

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure. MOCHA Investigators.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Differential effects of beta-blockers in patients with heart failure: A prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Sudden Cardiac Death

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Abnormal awake respiratory patterns are common in chronic heart failure and may prevent evaluation of autonomic tone by measures of heart rate variability

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Heart rate and blood pressure variabilities in salt-sensitive hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Age-dependent influence on heart rate variability in salt-sensitive hypertensive subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Influence of aging and other cardiovascular risk factors on baroreflex sensitivity

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Changes in repolarization dynamicity and the assessment of the arrhythmic risk

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

QT interval dynamics and heart rate variability preceding a case of cardiac arrest

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Qt dispersion has no prognostic information for patients with advanced congestive heart failure and reduced left ventricular systolic function

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

QT-interval variability and autonomic control in hypertensive subjects with left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

Ancillary diagnostic and therapeutic issues in cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2802%2902778-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9149(02)02778-9

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44210748&oldid=2108574469"